SORCS1 polymorphism and insulin secretion in obese women with polycystic ovary syndrome

Gynecol Endocrinol. 2016;32(5):395-8. doi: 10.3109/09513590.2015.1126818. Epub 2016 Jan 6.

Abstract

We investigated the influence of SORCS1 polymorphisms on insulin secretion in obese women with PCOS. Metabolic status was recorded in 50 clinically well characterized PCOS patients. Oral glucose tolerance test was performed and laboratory parameters of insulin resistance measured. All patients were genotyped for SORCS1 rs1358030, rs1416406 and rs11192966 polymorphisms. Statistical analysis was performed using the Mann-Whitney test. SORCS1 rs1416406 significantly influenced stimulated glucose plasma levels (p = 0.006) and increased glucose stimulated insulin secretion (p = 0.034). None of the polymorphisms influenced insulin resistance as measured by homeostatic model assessment. We report for the first time the relevance of SORCS1 polymorphisms for glycemic control and glucose stimulated insulin secretion in obese women with PCOS.

Keywords: Insulin resistance; SORCS1; polycystic ovary syndrome; polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose
  • Body Mass Index
  • Female
  • Glucose Tolerance Test
  • Humans
  • Insulin / blood*
  • Insulin Resistance / genetics*
  • Obesity / blood
  • Obesity / complications
  • Obesity / genetics*
  • Polycystic Ovary Syndrome / blood
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / genetics*
  • Polymorphism, Single Nucleotide*
  • Receptors, Cell Surface / genetics*

Substances

  • Blood Glucose
  • Insulin
  • Receptors, Cell Surface
  • SORCS1 protein, human